Biogen teams up with MedRhythms to develop MS digital therapeutic

The latest stories trending on MedCity News.

Not rendering correctly? View this email as a web page here. TOP STORIES Biogen gets in tune with MedRhythms to develop new digital therapeutic for MS Biogen struck a deal that could bring a digital therapeutic to its multiple sclerosis product portfolio. The drugmaker is partnering with startup MedRhythms in the development of a therapy that combines sensors, software, and music to improve walking problems in multiple sclerosis patients. SPONSORED Register Now For FREE! MedCity INVEST PharmaTech 2022 is a program dedicated to exploring the next chapter of the biopharma industry. Discussions will explore how pharma companies leverage digital innovations to achieve greater success and transform the lives of patients. Register Now StartUPDATES: New developments for healthcare startups By Stephanie Baum Friday, May 6, 2022 7:30 AM Read about new developments from Healthmine, Capable Health, Imagene AI, PolyCore Therapeutics, Inc and more. Read more » Healthcare hires of note By Stephanie Baum Friday, May 6, 2022 7:00 AM Here's a selection of recent executive hires across healthcare and life sciences. Read more » Even when IVF is covered by insurance, high bills and hassles abound By Phil Galewitz, Kaiser Health News Thursday, May 5, 2022 9:22 PM About 1 in 5 women have trouble getting pregnant, and IVF has become a common path to parenthood for many. But even as demand grows, insurance coverage remains limited. Read more » Novel drug-discovery approach lands big backers By Joel Berg Thursday, May 5, 2022 9:17 PM UK-based OMass Therapeutics is leaning on a proprietary form of native mass spectrometry to help develop small-molecule drugs for rare diseases. Read more » The next breakthrough in cancer treatment [Sponsored] By Isabel L. Jackson, PhD , director, Division of Translational Radiation Sciences at University of Maryland School of Medicine Thursday, May 5, 2022 2:16 PM An investigational treatment approach that may help us move beyond the limitations of normal tissue tolerance to radiation is clinically feasible for the first time. If successful, it could lead to profound changes in cancer care. Read more » How to regain trust in underserved communities such that it boosts pandemic readiness By Bob Genter Thursday, May 5, 2022 1:53 PM There are key strategies that can be leveraged by state, federal and local officials to assuage concerns of vaccine mistrust in BIPOC communities in a way that gives them the respect they currently lack and expand access to these life-saving drugs. Read more » MedCity News   611 Broadway    New York,  NY   10012   United States You received this email because you are subscribed to MedCity Daily Digest from MedCity News. Update your email preferences to choose the types of emails you receive.  Unsubscribe from all future emails